Cargando…

Health-Related Quality of Life Among Liver Disorder Patients in Northern India

OBJECTIVE: The present study aims to determine the health-related quality of life (HRQoL) among liver disorder patients being treated in tertiary care hospital in north India and exploration of factors affecting HRQoL. METHODOLOGY: The HRQoL was assessed among 230 patients visiting either the outpat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chugh, Yashika, Katoch, Swati, Sharma, Deepshikha, Bahuguna, Pankaj, Duseja, Ajay, Kaur, Manmeet, Dhiman, Radha Krishan, Prinja, Shankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971888/
https://www.ncbi.nlm.nih.gov/pubmed/35368487
http://dx.doi.org/10.4103/ijcm.ijcm_1033_21
Descripción
Sumario:OBJECTIVE: The present study aims to determine the health-related quality of life (HRQoL) among liver disorder patients being treated in tertiary care hospital in north India and exploration of factors affecting HRQoL. METHODOLOGY: The HRQoL was assessed among 230 patients visiting either the outpatient department (OPD) or those admitted in high dependency unit (HDU) or liver intensive care unit (ICU) using direct measuring tools such as Euro QoL five-dimension questionnaire (EQ-5D) and EQ visual analog scale. Multivariate regression was used to explore the factors influencing HRQoL. RESULTS: Mean EQ-5D scores among chronic hepatitis and compensated cirrhosis patients were 0.639 ± 0.062 and 0.562 ± 0.048, respectively. Among those who were admitted in the ICU or HDU, mean EQ-5D score was 0.295 ± 0.031. At discharge, this score improved significantly to 0.445 ± 0.055 (P < 0.001). The multivariate results implied that HRQoL was significantly better among patients with lower literacy level (P = 0.018) and those treated in OPD settings (P < 0.001). CONCLUSION: HRQoL is impaired among patients suffering from liver disorders specifically those admitted in ICU. Further, there is a need to generate more evidence to explore the impact of determinants and treatment-associated costs on the HRQoL.